(Q40543176)

21 September 2017

title

Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function (English)

1 reference

21 September 2017

1 reference

acute myeloid leukemia

1 reference

4

1 reference

21 September 2017

A Suvannasankha

1

1 reference

21 September 2017

H Minderman

2

1 reference

21 September 2017

K L O'Loughlin

3

1 reference

21 September 2017

W R Greco

5

1 reference

21 September 2017

D D Ross

6

1 reference

21 September 2017

M R Baer

7

1 reference

21 September 2017

language of work or name

1 reference

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

18

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

1252-1257

1 reference

BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Low levels of ABCG2 expression in adult AML blast samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Flow cytometric analysis of breast cancer resistance protein expression and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403395

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403395

1 reference

Dimensions Publication ID

21 September 2017

1026671793

0 references

1 reference